| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 06/23/2005 | US20050137158 Methods for targeting RNA molecules |
| 06/23/2005 | US20050137136 amino acid sequences which bind to gramnegative bacteria with high specificity, used for identification, detection, and isolation of bacteria, and for the delivery of nucleotides, proteins, toxins, liposomes and drugs to bacteria |
| 06/23/2005 | US20050137111 Thermostable amylase polypeptides, nucleic acids encoding those polypeptides and uses thereof |
| 06/23/2005 | US20050136525 Expression of granular starch hydrolyzing enzymes in Trichoderma and process for producing glucose from granular starch substrates |
| 06/23/2005 | US20050136524 Non-maltogenic exoamylase for use in improving quality of dough and baked goods |
| 06/23/2005 | US20050136515 Nucleotide sequences coding membrane protein for use in identifying modulators for prevention and treatment of cell proliferative, inflammatory, nervous system and autoimmune diseases |
| 06/23/2005 | US20050136477 Elution with quaternary onium containing compound; lysis free; one-step; kits |
| 06/23/2005 | US20050136475 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/23/2005 | US20050136474 Truncation SELEX method |
| 06/23/2005 | US20050136458 Method for nucleic acid preparation |
| 06/23/2005 | US20050136451 Hypoxia responsive human CNGH 0002 genes and polypeptides |
| 06/23/2005 | US20050136437 Nanoparticles for delivery of nucleic acids and stable double-stranded RNA |
| 06/23/2005 | US20050136433 Using mutation in intron-exon boundary of dihydropyrimidine dehydrogenase as indicator for modifying cancer treatment protocol |
| 06/23/2005 | US20050136430 Inhibitor nucleic acids |
| 06/23/2005 | US20050136418 Signal transducer and activator of transcription-6 (STAT) gene sequences comprising mutation for use as tool in detect of asthmatic, autoimmune, inflammatory and fibrotic disorders |
| 06/23/2005 | US20050136406 Methods of attaching biological compounds to solid supports using triazine |
| 06/23/2005 | US20050136404 Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics |
| 06/23/2005 | US20050136400 NS3-NS4A protease resistance mutants |
| 06/23/2005 | US20050136177 Method for coloring landscaping materials using foamable dry colorant |
| 06/23/2005 | US20050136068 Enzymatically inactive streptococcal C5a peptidase (SCP) conjugated or linked to one or more peptides; effective in immunizing a susceptible mammal against beta-hemolytic Streptococcus |
| 06/23/2005 | US20050136040 Peptide nucleic acid of a nucleic acid binding portion and a repressor portion of a polypeptide or peptidomimetic; drug design; gene expression inhibition |
| 06/23/2005 | CA2832293A1 Single nucleotide polymorphisms associated with cardiovascular disorders and statin response, methods of detection and uses thereof |
| 06/23/2005 | CA2550135A1 Complete mitochondrial genome sequences as a diagnostic tool for the health sciences |
| 06/23/2005 | CA2549397A1 Methods and compositions for genetically detecting improved milk production traits in cattle |
| 06/23/2005 | CA2549384A1 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis |
| 06/23/2005 | CA2548590A1 Methods and compositions for autism risk assessment background |
| 06/23/2005 | CA2548451A1 Methods of designing, synthesizing, and propagating reference nucleic acids |
| 06/23/2005 | CA2548180A1 Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells |
| 06/23/2005 | CA2548150A1 Polynucleotides for reducing respiratory syncytial virus gene expression |
| 06/23/2005 | CA2543257A1 Methods and compositions for delivering polynucleotides |
| 06/22/2005 | EP1544302A1 KNOCKIN NONHUMAN ANIMAL AND TISSUE-SPECIFIC MnSOD-KNOCKOUT NONHUMAN ANIMAL |
| 06/22/2005 | EP1543325A2 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof |
| 06/22/2005 | EP1543160A1 Uncoupling of dna propagation and expression of protein for phage display |
| 06/22/2005 | EP1543159A2 Antisense modulation of endothelial specific molecule 1 expression |
| 06/22/2005 | EP1543158A1 Regulated aptamer therapeutics |
| 06/22/2005 | EP1543156A2 Detection of chemical ligation using fluorescence quenching leaving groups |
| 06/22/2005 | EP1543154A2 Abasic site endonuclease assay |
| 06/22/2005 | EP1543150A2 Pna probes, probe sets, method and kits pertaining to the determination of listeria |
| 06/22/2005 | EP1543145A2 Antifungal therapeutic targets |
| 06/22/2005 | EP1543142A1 Production method for iturin a and its homologues |
| 06/22/2005 | EP1543109A2 Substances for preventing and treating autoimmune diseases |
| 06/22/2005 | EP1543024A2 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 06/22/2005 | EP1543021A2 Oligonucleotide conjugates |
| 06/22/2005 | EP1543019A2 Modified pna molecules |
| 06/22/2005 | EP1543018A1 Gene families associated with liver cancer |
| 06/22/2005 | EP1542945A2 Method for the production of zeaxanthin and/or the biosynthetic intermediates and/or subsequent products thereof |
| 06/22/2005 | EP1542725A2 Method of humanizing immune system molecules |
| 06/22/2005 | EP1542532A1 Spliceosome mediated rna trans-splicing for correction of skin disorders |
| 06/22/2005 | EP1218180A4 Multiple fluid sample processor with single well addressability |
| 06/22/2005 | EP1165763B1 Hydantoinase variants with improved properties and their use for the production of amino acids |
| 06/22/2005 | EP1007533B1 Bioconjugates and delivery of bioactive agents |
| 06/22/2005 | CN1630730A Methods for detecting and treating the early onset of aging-related conditions |
| 06/22/2005 | CN1630724A Compositions and methods for inhibiting expression of a target gene |
| 06/22/2005 | CN1629295A Citric acid synthesized enzyme gene and use thereof |
| 06/22/2005 | CN1629293A A rice blast resistance gene, its encoded protein and use thereof |
| 06/22/2005 | CN1629290A A shrimp gene PIAV and polypeptides coded thereby |
| 06/22/2005 | CN1629289A Susceptibility gene closely related to schizophrenia |
| 06/22/2005 | CN1629288A Recombinant Baculovirus for expressing CTB and human insulin fusion protein and use thereof |
| 06/22/2005 | CN1207388C Glyphosate degrading enzyme gene and carrier containing said gene |
| 06/22/2005 | CN1207387C Polypeptides and genes encoding same |
| 06/22/2005 | CN1207302C Method and compounds for curing diseases caused by mutations |
| 06/22/2005 | CA2490675A1 Process for high-yield synthesis of standard length and long-mer nucleic acid arrays |
| 06/21/2005 | US6908993 Comprises nucleotide sequences coding membrane protein for use in treatment of tumors and cell proliferative diseases; antiinflammatory agents |
| 06/21/2005 | US6908988 Animal models; medical diagnosis; antitumor agents |
| 06/21/2005 | US6908985 Heat-shock protein- binding proteins; useful in the regulation of physiological events in which one or more 70 kiloDalton heat-shock proteins (Hsp70) are involved, such as normal development, cellular stress responses, heart disease |
| 06/21/2005 | US6908758 Human kinase proteins and polynucleotides encoding the same |
| 06/21/2005 | US6908736 DNA sequencing method |
| 06/21/2005 | CA2182303C Method of preparing a viral vector by homologous intermolecular recombination |
| 06/21/2005 | CA2145749C Thrombin activatable plasminogen derivatives |
| 06/19/2005 | WO2006083240A2 Microbially expressed xylanases and their use as feed additives and other uses |
| 06/19/2005 | CA2548723A1 Microbially expressed xylanases and their use as feed additives and other uses |
| 06/16/2005 | WO2005054810A2 Polymorphic cd24 genotypes that are predictive of multiple sclerosis risk and progression |
| 06/16/2005 | WO2005054518A2 Compositions and their uses directed to bone growth modulators |
| 06/16/2005 | WO2005054502A1 Improved method for bisulfite treatment |
| 06/16/2005 | WO2005054438A2 Nucleic acid molecules containing recombination sites and methods of using the same |
| 06/16/2005 | WO2005054435A2 Methods and compositions for in vitro amplification of extrachromosomal nucleic acid |
| 06/16/2005 | WO2005054433A2 A novel “cleave-n-read” system for protease activity assay and methods of use thereof |
| 06/16/2005 | WO2005054427A2 Target sequences for synthetic molecules |
| 06/16/2005 | WO2005054292A1 Compositions and methods related to a dimeric mhc class i and ii-like molecule (dsmhc i and dsmhc ii) |
| 06/16/2005 | WO2005054236A1 Substituted quinolines for the treatment of cancer |
| 06/16/2005 | WO2005053738A1 Recombinant adenylate cyclase toxin of bordetella induces t cell responses against tumoral antigens |
| 06/16/2005 | WO2005053516A2 Replication competent hepatitis c virus and methods of use |
| 06/16/2005 | WO2005042578A3 Antibody fab fragment specific for breast cancer |
| 06/16/2005 | WO2005040386A3 A vector modification for versatile use of expressed products |
| 06/16/2005 | WO2005033652A3 Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol |
| 06/16/2005 | WO2005033144A3 Tim-3 polypeptides |
| 06/16/2005 | WO2005032495A8 Gene expression profiles and methods of use |
| 06/16/2005 | WO2005023091A3 Method for non-invasive prenatal diagnosis |
| 06/16/2005 | WO2005021585A3 Axmi-003, a delta-endotoxin gene and methods for its use |
| 06/16/2005 | WO2005018571A3 Compositions and methods for treating inflammatory lung disease |
| 06/16/2005 | WO2005005598A3 B. anthracis luxs and furanone inhibition of a1-2 quorum sensing |
| 06/16/2005 | WO2005003154A8 Compositions and methods for the diagnosis and treatment of tumor |
| 06/16/2005 | WO2005000235A3 NUCLEIC ACID SEQUENCES ENCODING AND COMPOSITIONS COMPRISING IgE SIGNAL PEPTIDE AND/OR IL-15 AND METHODS FOR USING THE SAME |
| 06/16/2005 | WO2004087877A3 Selected rna motifs to include cell death and/or apoptosis |
| 06/16/2005 | WO2004084804A3 Detection and monitoring of lung cancer |
| 06/16/2005 | WO2004058166A3 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection |
| 06/16/2005 | WO2003033646A3 Compositions and methods for the modulation of viral maturation |
| 06/16/2005 | US20050132442 Expression vector comprising nucleotide sequences coding fungal fatty acid desaturase for use in generating transgenic organism with enhanced concentrations of alpha-linolenic acid |
| 06/16/2005 | US20050132441 Delta15 desaturases suitable for altering levels of polyunsaturated fatty acids in oilseed plants and oleaginous yeast |
| 06/16/2005 | US20050132428 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |